Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This study is an an open-label Phase I trial of VT1021 in patients with advanced solid
tumors. Patients must have recurrent or advanced cancer (i.e., solid tumors) for which
standard therapy offers no curative potential.